Skip to content

Clinical trials

Completed Thalassemia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thalassemia Status: Completed Country / region: United States Clear all

60 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20022
20033
20042
20052
20063
20072
20087
20097
20103
20112
20125
20131
20142
20152
20161
20171
20184
20191
20222
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed60

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Carelon Research7
UCSF Benioff Children's Hospital Oakland6
Novartis Pharmaceuticals5
University of California, San Francisco4
National Heart, Lung, and Blood Institute (NHLBI)3
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)3
Novo Nordisk A/S3
St. Jude Children's Research Hospital3
Children's Hospital Los Angeles2
Duke University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thalassemia60
Anemia, Sickle Cell31
Anemia, Diamond-Blackfan11
Hemoglobinopathies11
Iron Overload11
beta-Thalassemia11
Anemia6
Genetic Diseases, Inborn5
Hypertension, Pulmonary5
Immunologic Deficiency Syndromes5

Trials

Showing 1 to 25 of 60. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.